We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$2.09B
AUM Growth
-$289M
Cap. Flow
-$380M
Cap. Flow %
-18.22%
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$11.6M
2
PSX icon
Phillips 66
PSX
+$11.1M
3
MET icon
MetLife
MET
+$10.1M
4
M icon
Macy's
M
+$9.08M
5
ORLY icon
O'Reilly Automotive
ORLY
+$8.37M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.7M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$10.7M
3
GAP
The Gap Inc
GAP
+$8.4M
4
UAL icon
United Airlines
UAL
+$8.14M
5
SKX
Skechers
SKX
+$7.54M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.17%
2 Industrials 14.75%
3 Technology 13.58%
4 Healthcare 12.19%
5 Financials 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDOW icon
451
ProShares UltraPro Short Dow 30
SDOW
$145M
$698K 0.03%
103
+36
+54% +$257K
XLS
452
DELISTED
EXELIS INC COM STK
XLS
$696K 0.03%
+43,908
New +$724K
JOYY
453
JOYY Inc
JOYY
$3.73B
$682K 0.03%
9,030
+1,300
+17% +$84.8K
UFS
454
DELISTED
DOMTAR CORPORATION (New)
UFS
$679K 0.03%
+15,849
New +$743K
SPXU icon
455
ProShares UltraPro Short S&P 500
SPXU
$414M
$676K 0.03%
36
+14
+64% +$297K
MMYT icon
456
MakeMyTrip
MMYT
$5.93B
$674K 0.03%
+19,200
New +$488K
WUBA
457
DELISTED
58.com Inc
WUBA
$671K 0.03%
+12,420
New +$527K
DWCH
458
DELISTED
Datawatch Corp
DWCH
$670K 0.03%
44,761
-4,934
-10% -$74.8K
CNK icon
459
Cinemark Holdings
CNK
$4.39B
$665K 0.03%
18,811
-8,732
-32% -$267K
SQQQ icon
460
ProShares UltraPro Short QQQ
SQQQ
$1.89B
$661K 0.03%
2
+1
+100% +$513K
TVRD
461
Tvardi Therapeutics
TVRD
$18.9M
$656K 0.03%
+1,071
New +$577K
LXK
462
DELISTED
Lexmark Intl Inc
LXK
$656K 0.03%
13,616
-1,398
-9% -$62.4K
SON icon
463
Sonoco
SON
$5.57B
$655K 0.03%
14,920
-9,313
-38% -$394K
KYTH
464
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$649K 0.03%
16,903
+5,103
+43% +$178K
DUK icon
465
Duke Energy
DUK
$96.7B
$647K 0.03%
8,719
-29,598
-77% -$2.13M
EQR icon
466
Equity Residential
EQR
$25.1B
$636K 0.03%
10,094
-9,455
-48% -$574K
PRA
467
DELISTED
ProAssurance
PRA
$635K 0.03%
14,298
-1,378
-9% -$61.6K
THG icon
468
Hanover Insurance
THG
$8.11B
$635K 0.03%
10,054
-492
-5% -$29.9K
WGO icon
469
Winnebago Industries
WGO
$879M
$630K 0.03%
25,030
-30,831
-55% -$758K
CFR icon
470
Cullen/Frost Bankers
CFR
$10.5B
$622K 0.03%
7,827
-5,013
-39% -$386K
PRKS icon
471
United Parks & Resorts
PRKS
$2.12B
$619K 0.03%
21,838
+13,787
+171% +$416K
JMEI
472
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$619K 0.03%
+2,276
New +$601K
CAMP
473
DELISTED
CalAmp Corp.
CAMP
$605K 0.03%
+1,214
New +$570K
DOC icon
474
Healthpeak Properties
DOC
$15B
$583K 0.03%
15,482
-12,350
-44% -$465K
CCIH
475
DELISTED
Chinacache International Holdings Ltd
CCIH
$579K 0.03%
+36,990
New +$564K

Similar funds

Cadence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.

  • Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
  • Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
  • Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
  • Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
  • Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
  • Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
  • Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.